Pharmaceutical

Almirall completes EU regulatory procedure for antifung...

Oct 16, 2024

Almirall has completed the decentralised regulatory procedure in Europe for efin...

Parenteral Solutions in Contract Manufacturing for the ...

Oct 16, 2024

Discover the leading Parenteral Solutions in Pharmaceutical Contract Manufacturi...

The growing role of CDMOs in the circular economy

Oct 16, 2024

Pharmaceutical giants cannot work in a silo to reach net zero. Pharma contract m...

Hanmi and MEDiC ink cancer biomarker collaboration deal

Oct 16, 2024

The agreement will see MEDiC’s MCAT platform identify biomarkers to support the ...

Lilly touts Omvoh’s superiority over J&J’s Stelara in C...

Oct 16, 2024

Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last...

Bayer applies for EU approval of menopause drug elinzan...

Oct 16, 2024

Bayer notches up pressure on rival Astellas’ Veozah with an EU marketing authori...

Transgene’s stock drops after Phase II cancer jab trial...

Oct 16, 2024

Despite this setback, Transgene plans to explore the potential benefits of the v...

GITEX GLOBAL 2024: Huawei launches a series of industri...

Oct 16, 2024

Huawei hosted GITEX's Industrial Digital and Intelligent Transformation Summit a...

Digital twins: A new path to personalised medicine

Oct 16, 2024

digital twins can be used to progress healthcare, drug development, and research...

The science of viscous drug product filling: Pumps, pre...

Oct 16, 2024

Cell and gene therapy approvals drive paradigm change i...

Oct 14, 2024

Trends in gene therapy approvals in recent years are rapidly shaping the future ...

XtalPi’s AI biologics discovery platform licensed to Ja...

Oct 12, 2024

XtalPi's AI biologics discovery platform, XtalFold, has been licensed to Janssen...

Activist investor Starboard cries foul play in exec U-t...

Oct 12, 2024

Starboard has accused Pfizer of “coercive conduct” after executives who initiall...

Booster Therapeutics to develop proteasome activator me...

Oct 12, 2024

Booster Therapeutics has announced its inception to develop a new class of prote...

KeyBioscience and Eli Lilly extend partnership for obes...

Oct 12, 2024

KeyBioscience and Eli Lilly have extended their partnership to develop a new cla...

CPHI Europe: Targeting supply chain bottlenecks key for...

Oct 12, 2024